WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced the pending departure of William Kelly, its Chief Financial Officer (CFO), to pursue other career opportunities, after nearly four years of dedicated service with the Company. Mr. Kelly has served as Vicarious Surgical's CFO since January 2021. He will assist.
Vicarious Surgical Inc (NYSE:RBOT ) Q2 2024 Results Conference Call August 12, 2024 4:30 PM ET Company Participants Kaitlyn Brosco - IR Bill Kelly - CFO & Treasurer Adam Sachs - Co-Founder, CEO & Director Conference Call Participants Eric Anderson - TD Cowen Andrew Ranieri - Morgan Stanley Ryan Zimmerman - BTIG Operator Good afternoon. Thank you for attending the Vicarious Surgical's 2024 Second Quarter Earnings Call.
Vicarious Surgical (RBOT) teams up with LSU Health New Orleans to advance its V1.0 surgical robot. It aims to file for FDA approval by 2026.
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives through the transformation of surgical robotics, today announced it will effect a 1-for-30 reverse stock split of the Company's issued and outstanding Class A common stock, par value $0.0001 per share, and Class B common stock, par value $0.0001 per share. The reverse stock split was approved by Vicarious S.
Vicarious Surgical (NYSE: RBOT) recently released their first quarter results for 2024, with earnings per share of -9 cents.
Vicarious Surgical Inc. (NYSE:RBOT) will be hosting its Q1 2024 Earnings Conference Call on April 29, 2024 at 4:30 PM ET. The call will feature Kaitlyn Brosco, Adam Sachs, Bill Kelly, and Randy Clark. Participants include Ryan Zimmerman, Adam Maeder, and Josh Jennings. The operator will start the call by welcoming everyone to Vicarious Surgical's 2024 First Quarter Earnings Call.
Vicarious Surgical Inc. (NYSE:RBOT ) Q4 2023 Earnings Conference Call March 4, 2024 4:30 PM ET Company Participants Kaitlyn Brosco - IR Adam Sachs - CEO William Kelly - CFO Conference Call Participants Ryan Zimmerman - BTIG Operator Good afternoon, and welcome to Vicarious Surgical's Fourth Quarter 2023 Earnings Conference Call. My name is Matt, and I'll be your operator for today's call.
Vicarious Surgical Inc. (NYSE:RBOT ) Q3 2023 Earnings Conference Call November 13, 2023 4:30 PM ET Company Participants Kaitlyn Brosco - Investor Relations Adam Sachs - Chief Executive Officer Bill Kelly - Chief Financial Officer Conference Call Participants Ryan Zimmerman - BTIG Adam Maeder - Piper Sandler Josh Jennings - TD Cohen Caitlin Cronin - Canaccord Genuity Operator Good afternoon, and welcome to Vicarious Surgical's Third Quarter 2023 Earnings Conference Call. My name is Kate, and I'll be your operator for today's call.
Vicarious Surgical's (RBOT) partnership with Intermountain Health is likely to help the company gain access to Intermountain Health's extensive network.
Vicarious Surgical is a surgical robotics company developing a next-generation surgical robot with human-like dexterity. The company has a large addressable market of over 45 million abdominal procedures worth $150 billion, but its survival is uncertain due to low cash reserves and high burn. I am personally staying on the sidelines as I believe the risk / reward is better if/when RBOT reaches commercialization with a superior product than currently awaiting regulatory approval.